Initial Director's Interest Notice - Michael Sistenich
Latest announcements
Announcement summary
Initial Director's Interest Notice - Michael Sistenich
Resonance Health Limited hereby discloses the initial director's interest notice for Michael Sistenich, appointed on 28th April 2026. As per the listing rule 3.19.A.1, Michael Sistenich holds nil securities as a registered holder and nil securities as a non-registered holder. There are no interests in contracts to report at this time.
For further details or inquiries regarding this disclosure, we encourage investors to reach out to our investor relations department. Thank you for your continued interest and support in Resonance Health Limited.
AI-Generated Summary: This content may contain inaccuracies. Neither the Company nor InvestorHub assumes responsibility for its accuracy. Please refer to the full announcement before making any investment decision.
Ask a question
Your question will be sent privately to Resonance Health. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Resonance Health a question about this announcement.